Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2012

01.08.2012 | Gynecologic Oncology

The potential prognostic value of cathepsin D protein in serous ovarian cancer

verfasst von: Yun Chai, Weiwei Wu, Caiyun Zhou, Jianhong Zhou

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Overexpression of a ubiquitous lysosomal aspartyl protease cathepsin D (cath-D) is involved in the progression of certain cancer types. This study investigated the prognostic value of the cath-D expression and its association with other known clinicopathological parameters in serous ovarian carcinoma.

Materials and methods

Cath-D was detected by immunohistochemistry in 49 serous ovarian carcinomas and compared to 50 benign serous ovarian tumors. The results were correlated with clinicopathological characteristics and survival outcomes.

Results

In both cath-D positive benign and malignant serous ovarian tumors, a specific granular cytoplasmic staining was observed in both epithelial and stromal cells. Cath-D expression levels were higher in serous ovarian carcinomas than in benign tumors (P < 0.01). Cath-D expression in tumor epithelial cells correlated with mesenchymal cell expression (P < 0.001). The cath-D expression levels of tumor epithelial cells correlated with residual tumor size (P = 0.027) and was not related to other factors (P > 0.05). Patients with higher cath-D expression in epithelial cells had longer disease-free survival time (DFST; P = 0.025) and overall survival time (OST; P = 0.030). Through the Cox regression test, we found that the response to treatment (P < 0.001), pathological stage (P < 0.001), and peritoneal cytology results (P = 0.018) were independent effect factors for DFST. The expression level of cath-D in epithelial cells (P = 0.025), response to treatment (P < 0.001), pathological stage (P = 0.001), and peritoneal cytology results (P = 0.002) were independent effect factors for OST.

Conclusion

This showed that cath-D was an indicator of malignancy in serous ovarian carcinoma. It was expressed more highly in serous ovarian carcinoma than benign serous ovarian tumor. Additionally, our results suggested that high expression of cath-D in tumor epithelial cells was a favorable survival prognostic factor for serous ovarian carcinoma.
Literatur
1.
Zurück zum Zitat Bell DA (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18(Suppl 2):S19–S32PubMedCrossRef Bell DA (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18(Suppl 2):S19–S32PubMedCrossRef
2.
Zurück zum Zitat Nomura T, Katunuma N (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 52(1–2):1–9PubMedCrossRef Nomura T, Katunuma N (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 52(1–2):1–9PubMedCrossRef
3.
Zurück zum Zitat Clinton GM, Hua W (1997) Estrogen action in human ovarian cancer. Crit Rev Oncol Hematol 25(1):1–9PubMedCrossRef Clinton GM, Hua W (1997) Estrogen action in human ovarian cancer. Crit Rev Oncol Hematol 25(1):1–9PubMedCrossRef
4.
Zurück zum Zitat Berchem G, Glonda M, Gleizes M et al (2002) Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21(38):5951–5955PubMedCrossRef Berchem G, Glonda M, Gleizes M et al (2002) Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21(38):5951–5955PubMedCrossRef
5.
Zurück zum Zitat Leto G, Tumminello FM, Crescimanno M et al (2004) Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis 21(2):91–106PubMedCrossRef Leto G, Tumminello FM, Crescimanno M et al (2004) Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis 21(2):91–106PubMedCrossRef
6.
Zurück zum Zitat Rochefort H (1992) Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 28A(11):1780–1783PubMedCrossRef Rochefort H (1992) Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 28A(11):1780–1783PubMedCrossRef
7.
Zurück zum Zitat Foekens JA, Look MP, Bolt-de Vries J et al (1999) Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 79(2):300–307PubMedCrossRef Foekens JA, Look MP, Bolt-de Vries J et al (1999) Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 79(2):300–307PubMedCrossRef
8.
Zurück zum Zitat Henzen-Logmans SC, Fieret EJ, Berns EM et al (1994) Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal growth factor receptor and cathepsin D. Int J Cancer 57(4):468–472PubMedCrossRef Henzen-Logmans SC, Fieret EJ, Berns EM et al (1994) Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal growth factor receptor and cathepsin D. Int J Cancer 57(4):468–472PubMedCrossRef
9.
Zurück zum Zitat Baekelandt M, Holm R, Trope CG et al (1999) The significance of metastasis-related facts cathepsin-D and nm23 in advanced ovarian cancer. Ann Oncol 10(11):1335–1341PubMedCrossRef Baekelandt M, Holm R, Trope CG et al (1999) The significance of metastasis-related facts cathepsin-D and nm23 in advanced ovarian cancer. Ann Oncol 10(11):1335–1341PubMedCrossRef
10.
Zurück zum Zitat Scambia G, Panici PB, Ferrandina G et al (1994) Clinical significance of cathepsin D in primary ovarian cancer. Eur J Cancer 30A:935–940PubMedCrossRef Scambia G, Panici PB, Ferrandina G et al (1994) Clinical significance of cathepsin D in primary ovarian cancer. Eur J Cancer 30A:935–940PubMedCrossRef
11.
Zurück zum Zitat Ferrandina G, Scambia G, Fagotti A et al (1998) Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome. Br J Cancer 78(12):1645–1652PubMedCrossRef Ferrandina G, Scambia G, Fagotti A et al (1998) Immunoradiometric and immunohistochemical analysis of cathepsin D in ovarian cancer: lack of association with clinical outcome. Br J Cancer 78(12):1645–1652PubMedCrossRef
12.
Zurück zum Zitat Athanassiadou P, Sakellariou V, Petrakakou E et al (1998) Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors. Pathol Oncol 4(2):103–107CrossRef Athanassiadou P, Sakellariou V, Petrakakou E et al (1998) Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors. Pathol Oncol 4(2):103–107CrossRef
13.
Zurück zum Zitat Losch A, Schindl M, Kohlberger P et al (2004) Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Gynecol Oncol 92(2):545–552PubMedCrossRef Losch A, Schindl M, Kohlberger P et al (2004) Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Gynecol Oncol 92(2):545–552PubMedCrossRef
14.
Zurück zum Zitat Nisolle M, Casanas RF, Donnez J (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68(5):912–919PubMedCrossRef Nisolle M, Casanas RF, Donnez J (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68(5):912–919PubMedCrossRef
15.
Zurück zum Zitat Dvalishvili I, Charkviani L, Charkviani T et al (2005) Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma. Georgian Med News 126:27–31PubMed Dvalishvili I, Charkviani L, Charkviani T et al (2005) Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma. Georgian Med News 126:27–31PubMed
16.
Zurück zum Zitat Rodríguez J, Vázquez J, Corte MD et al (2005) Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. Int J Biol Markers 20(2):103–111PubMed Rodríguez J, Vázquez J, Corte MD et al (2005) Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. Int J Biol Markers 20(2):103–111PubMed
17.
Zurück zum Zitat Abbott DE, Margaryan NV, Jeruss JS et al (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9(1):23–30PubMedCrossRef Abbott DE, Margaryan NV, Jeruss JS et al (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9(1):23–30PubMedCrossRef
18.
Zurück zum Zitat Maygarden SJ, Novotny DB, Moul JW et al (1994) Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7(9):930–9366PubMed Maygarden SJ, Novotny DB, Moul JW et al (1994) Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7(9):930–9366PubMed
19.
Zurück zum Zitat Holm R, Tanum G (1996) Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study. Virchows Arch 428(2):85–89PubMedCrossRef Holm R, Tanum G (1996) Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study. Virchows Arch 428(2):85–89PubMedCrossRef
20.
Zurück zum Zitat Axel SM, Joerg H, Perikles S et al (2005) Translational research: from lab to clinic: cathepsin D expression in renal cell cancer clinical implications. Eur Urol 48:519–526CrossRef Axel SM, Joerg H, Perikles S et al (2005) Translational research: from lab to clinic: cathepsin D expression in renal cell cancer clinical implications. Eur Urol 48:519–526CrossRef
Metadaten
Titel
The potential prognostic value of cathepsin D protein in serous ovarian cancer
verfasst von
Yun Chai
Weiwei Wu
Caiyun Zhou
Jianhong Zhou
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2318-2

Weitere Artikel der Ausgabe 2/2012

Archives of Gynecology and Obstetrics 2/2012 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.